News search

    E.g., 20/06/2026
    E.g., 20/06/2026
    About the CNIC
    6 Aug 2021
    RREBOOT, on a mission to change clinical practice guidelines for the treatment of heart attack survivors

    CNIC and the Mario Negri Institute in Milan (Italy) coordinate REBOOT, a project that aims to study whether treatment with beta-blockers is beneficial for patients who have suffered a myocardial infarction

    Association between the level of glycosylated hemoglobin and the extent of subclinical atherosclerosis
    Research
    31 May 2021
    JACC: A blood sugar biomarker identifies patients with atherosclerosis and a risk of cardiovascular events

    In an article published in JACC, CNIC scientists report a method for improved ranking of cardiovascular risk in individuals without diabetes
    About the CNIC
    10 Dec 2020
    'AngioUnrestUHD', led by Dr. Rui Benedito, awarded ERC Consolidator funding in the ERC-2020-COG call for proposals

    AngioUnrestUHD, will develop and apply new research tools and methods to advance knowledge about the biology of blood vessels in distinct physiological and pathological contexts
    Atrial electroanatomic map of a pig with persistent AFib. The regions colored magenta, purple, and dark blue have high mean FM values. These regions maintain the AFib, and their ablation with a catheter stops the arrhythmia. The squares represent the sites of rotational activity, which are sensitive but not specific to the regions that maintain the fibrillation.
    Research
    12 Sep 2019
    Circulation Research: A new method to improve treatment of atrial fibrillation

    The new study was conducted by investigators at the CNIC, the Hospital Clínico San Carlos in Madrid, and the CiberCV research network and is featured on the cover of the latest edition of the journal Circulation Research

    About the CNIC
    18 Jan 2019
    The Pro CNIC Foundation extends its commitment with the CNIC until 2028
    • ·         The Pro CNIC Foundation prolongs its commitment until 2028, with the excellent cardiovascular research carried out at the CNIC under the management of Dr. Valentín Fuster
    • ·         The innovative public-private financing formula has allowed the CNIC to reach a very high level of excellence, making it worthy of the Severo Ochoa accreditation and other international recognitions 
    • The Pro CNIC joins together 12 of the most important companies in Spain: Acciona, Santander Bank, BBVA, Endesa, Mapfre Foundation, Mutua Madrileña Foundation, Ramón Areces Foundation, Repsol Foundation, Inditex, "la Caixa", Prisa and Telefónica.
    Foto
    Research
    19 Nov 2018
    The CNIC Conference addresses the emerging concepts of cardiovascular biology

    The scientific event, which took place in Madrid, brought together more than 100 researchers from different fields of cardiovascular biology

    Research
    16 Nov 2018
    Nature Communications: Blocking hypertension with antihypertensive drugs prevents the development of a lethal disease

    The study results, published in the journal Nature Communications, identify several proteins implicated in this disease
    Los participantes de la CNIC Conference
    About the CNIC
    13 Nov 2017
    The 2017 CNIC Conference on atrial fibrillation combined a global perspective from the genetic basis to the new advances in clinical treatment

    The CNIC Conference entitled “Atrial Fibrillation: from Mechanisms to Population Science”, joined together 126 world experts in the field of atrial fibrillation in very different areas of expertise
    Photo 1: The authors are holding in their hands illustrations of cells expressing different combinations of membrane and nuclei fluorescent proteins. This corresponds to the method we developed (present in the article) to differentially label cells expressing different genes (with the codes A to F). Each cell expresses a different combination of 2 genes from a pool of 6 different genes (A, B, C, D, E, and F).
    Publications
    10 Aug 2017
    Cell: CNIC Scientists develop new methods for analyzing gene function

    The study, published in Cell, will allow any researcher to induce multispectral genetic mosaics in vertebrate research models such as mice and zebrafish
    Alberto Sanz, Gerente del CNIC; Dr. Jordi Camí, director de la Fundación Pasqual Maragall; Dr. Valentín Fuster, director general del CNIC, y Dr. Borja Ibáñez, Director de Investigación Clínica del CNIC.
    About the CNIC
    30 May 2017
    Two of the of the largest research cohorts in Spain join together to work on the prevention of atherosclerosis and Alzheimer’s

    Los resultados permitirán avanzar en el conocimiento de la interacción entre los diversos factores de riesgo de ambas enfermedades